Genmab
Copenhagen · Founded 1999
About Genmab
Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. Its discovery, development, and manufacturing teams are using cutting-edge technology to create and develop products to address unmet medical needs.
Company Facts
- Founded: 1999
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $1M – $10M
- Total funding: $11.7B
- Funding stage: IPO
- Last round: Post-IPO Debt (Nov 2025)
- Ticker: cph:GEN
- Website: genmab.com
- Phone: + 45 7020 2728
Industries & Categories
Biotechnology, Health Care, Manufacturing, Medical
Social Profiles
Canonical: https://fsome.com/organization/genmab-29525 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.